PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Title only   |   Print    Next page > 
     
Ivonescimab Meets Overall Survival Key Secondary Endpoint in Interim Analysis of Phase III HARMONi-2 Study, Demonstrating Statistically Significant and Clinically Meaningful Benefit Versus Pembrolizumab in First-Line PD-L1-Positive NSCLC
HONG KONG , Sept. 3, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that a pre-specified interim analysis of overall survival (OS) in the HARMONi-2 ...
2026-09-03T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
EpiVax Launches AI-Enhanced Models for Immunogenicity Prediction
PROVIDENCE, R.I. , Sept. 3, 2026 /PRNewswire/ -- EpiVax, Inc. is pleased to announce the release of AI-enabled enhancements to ISPRI™ , its proprietary in silico platform for assessing the immunogenicity ...
2026-09-02T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Alteogen Enters Option and License Agreement with Novartis for Development and Commercialization of Hybrozyme™-Enabled Subcutaneous Products
Novartis obtains rights to develop and commercialize subcutaneous formulations for multiple products utilizing ALT-B4 Alteogen's fourth licensing agreement signed this year further accelerating the ...
2026-09-02T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
NovaGo Therapeutics Closes USD 30 Million Series B Financing to Advance Proof-of-Concept Study in Acute Spinal Cord Injury
Round led by Neurimmune and Pureos, with participation from existing and new investors; complemented by non-dilutive funding from the Swiss Paraplegic Foundation and Wings for Life - Spinal Cord Research ...
2026-09-02T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Norroy Bioscience Initiates Pivotal Phase III Clinical Trial of 177Lu-NYM032, a PSMA-Targeted Radioligand Therapy for mCRPC
WUXI, China , Sept. 2, 2026 /PRNewswire/ -- NORROY BIOSCIENCE (NORROY) , a clinical-stage biotechnology company focused on innovative targeted radiopharmaceuticals, announced that it has received regulatory ...
2026-09-02T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Despite nationwide basic stroke treatment coverage, delays accessing advanced stroke care in Vietnam vary by region, new report finds
Patients in Vietnam's Southwest region and Mekong Delta can travel up to ten hours for advanced stroke care;   Vietnamese experts point to a public-private model in Can Tho as a way to close that ...
2026-09-02T    Health Care/Hospital   Medical/Pharmaceuticals 
Workforce shortages and limited public hospital capacity remain major barriers to stroke care in the Philippines, new report finds
Filipino experts call for equipping more public hospitals with advanced imaging technology, stronger EMS infrastructure and greater investment in specialist training to close these gaps ...
2026-09-02T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Delays before patients reach stroke centres remain a major barrier to timely treatment in Malaysia, new report finds
Malaysia experts call for better public awareness of stroke symptoms, standardised hospital imaging protocols and expanded access to specialist care beyond major urban centres ...
2026-09-02T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Delays Before Patients Reach Stroke Centers Still Hinder Timely Treatment Across Southeast Asia, Siemens Healthineers Report Finds
New research commissioned by Siemens Healthineers shows transportation delays, slow reporting processes as leading barriers to timely stroke diagnosis. ...
2026-09-02T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
"From Canine Fat Tissue to Insulin-Producing Cells": Chula Veterinary Researchers Offer New Hope for Diabetes Treatment in Pets
While diabetes is commonly associated with humans, the disease also affects dogs and cats. Its impact on the quality of life of both pets and their owners is often greater than many people realize. ...
2026-09-02T    Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.